KESIMPTA RESOURCES
KESIMPTA resources for every step of the way |
Choosing your RMS treatment?
You can take an active role in this decision. Use this guide to get prepared with the right questions to ask your doctor.
Considering KESIMPTA? Start here.
This brochure shows you what KESIMPTA is all about—from results and safety to dosing and details on financial assistance.
Get the guide to help voice your needs.
Jamie Lynn Sigler’s 3-step guide was designed to help you advocate for yourself and your RMS treatment.
Learn how to take KESIMPTA here.
Here are some tips for using the KESIMPTA Sensoready® Pen.
Decided to start KESIMPTA?
Your doctor may have already filled out this Start Form, but check these instructions to see what comes next.
Recursos en espaol |
¿Considerando KESIMPTA? Empieza aquí.
Vea de qué se trata KESIMPTA: desde los resultados y la seguridad hasta el esquema posológico, e incluso información sobre la asistencia financiera.
Lea cómo se usa
Aquí hay algunos consejos para la administración de KESIMPTA con la Sensoready® Pluma.
¿Está decidido a usar KESIMPTA?
Posiblemente su médico ya completó un formulario inicial, pero observe a continuación.
“Pasé un tiempo investigando opciones teniendo en cuenta mi estilo de vida, y mi médico y yo sentimos que KESIMPTA era la mejor opción.”
¿Aún necesita más instrucciones?
Vea este video para obtener más instrucciones paso a paso sobre cómo usar la Sensoready® Pluma.
Check out Life on KESIMPTA Videos
The KESIMPTA Crew share what they've learned while living with RMS.
We’ve got answers about KESIMPTA
Hear from people who take KESIMPTA: the KESIMPTA Crew
Want more information to help you decide?
Find out why so many people are choosing KESIMPTA.
Want co-pay help?
97% of all prescriptions filled have a $0 out of pocket cost when used with the Access Card*† from the Alongside™ KESIMPTA Patient Support Program.
RMS, relapsing multiple sclerosis.
*Limitations apply. Offer not valid under Medicare, Medicaid, or any other federal or state health insurance program. Patients with commercial insurance who are initially denied coverage may receive free KESIMPTA for up to 12 months while seeking coverage. Patients with commercial insurance who have coverage for KESIMPTA may receive up to $18,000 in annual co-pay benefits. Novartis reserves the right to rescind, revoke, or amend this program without notice. Additional limitations may apply. See complete Terms & Conditions at start.kesimpta.com.
†2023 data on file.